Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02934568
Title Ribociclib (LEE011) Rollover Study for Continued Access
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

Advanced Solid Tumor

Therapies

Ribociclib

Age Groups: senior | adult | child
Covered Countries USA | FRA | ESP


No variant requirements are available.